Investing Profile
David Mott
InvestorVC
Private Investor at Mott Family Capital
Montana
Your Intro Paths to David Mott
Networks David is a member of
Dartmouth College Network
80 CONNECTIONS
New Enterprise Associates (NEA) Network
42 CONNECTIONS
Find David Mott on
cbCurrent Investing Position
Mott Family Capital Investor
Investment Range
$100K - $10.0M
Sweet Spot
$1M
Investments On Record
18
David Mott is on these Sector & Stage Rankings
David Mott's Investments On Record (12)
| Company | StageDateRound Size | Total Raised |
|---|---|---|
Sagimet Biosciences | Series EAug 2019$7M Series BJul 2009$30M | $190M |
Cydan | Series UnknownOct 2017$34M  Series UnknownOct 2013$10M Series UnknownApr 2013$16M | $60M |
Nightstar Therapeutics | Series CJun 2017$45M Series BNov 2015$35M  | $80M |
Vtesse | Series AJul 2016$17M | $17M |
Ardelyx | Post Ipo EquityJul 2016$110M Post Ipo EquityJun 2015$78M Series BAug 2011$30M | $220M |
Clementia Pharmaceuticals | Series UnknownJun 2015$60M | $93M |
XTuit Pharmaceuticals | Series AJun 2015$22M | $22M |
Adaptimmune | Series ASep 2014$100M | $100M |
David Mott's Experience
Private Investor Mott Family Capital2020 - Present
Chairman Imara, Inc2016 - Present
Chairman Adaptimmune2014 - Present
Chairman Mersana Therapeutics2013 - Present
Chairman Epizyme2009 - Present
Chairman Ardelyx, Inc.2008 - Present
Board Member Polyneuron Pharmaceuticals AG2019 - 2020
Board Member Tiburio Therapeutics2019 - 2020
Chairman Cydan Development, Inc.2013 - 2020
Chairman 3-V Biosciences2008 - 2020
General Partner New Enterprise Associates (NEA)2008 - 2020
Board Member NightstaRx Limited2015 - 2019
Chairman TESARO, Inc.2010 - 2019
Board Member Clementia Pharmaceuticals2015 - 2018
Board Member XTuit Pharmaceuticals, Inc.2015 - 2018
Chairman Vtesse, Inc.2015 - 2017
Board Member Edimer Pharmaceuticals2013 - 2016
Chairman Prosensa2012 - 2014
Chairman Zyngenia, Inc2009 - 2014
Member Board of Trustees St. Albans School (D.C.)2008 - 2014
Board Member Omthera Pharmaceuticals, Inc.2011 - 2013
Board Member Shire2007 - 2008
Board Member RibX Pharmaceuticals2006 - 2008
President & Chief Executive Officer, Vice Chairman MedImmune2000 - 2008
Board Member Ambit Pharmaceuticals2004 - 2007
Member of the Board of Trustees Beauvoir Elementary School2001 - 2007
Chairman Conceptis1999 - 2003
Member of the Board of Trustees Saint James School1997 - 2003
Various Positions: President, Chief Operating Officer, Chief Financial Officer, EVP, VP, etc... MedImmune1992 - 2000
Various Positions: Vice President, Associate, Analyst Smith Barney, Harris Upham & Co.1986 - 1992
David Mott's Education
Dartmouth College Bachelor’s Degree Economics and Government
Saint James School High School